WVE News and Press, Wave Life Sciences Ltd. From 10/30/22

Summary Two new Breakout Stocks for Week 44 with better than 10% short-term upside potential and a Dow 30 Pick. Average cumulative returns now up to +112.8% YTD. This week two stocks gained 10% in less than a week with MAG +11.5% and WTTR +10% while another high frequency breakout...

Summary Two new Breakout Stocks for Week 43 with better than 10% short-term upside potential and two Dow 30 Picks. Average cumulative returns now up to +110.6% YTD. This week one stock beat 10% in less than a week with TOST +13.8% while other high frequency breakout picks peaked m...

Summary Two new Breakout Stocks for Week 42 with better than 10% short-term upside potential and two Dow 30 picks. Average cumulative returns now up to +107.1% YTD. This week no stock picks beat 10% in less than a week and we continue in bear funds +41.4% YTD following the negativ...

Cheap Penny Stocks To Buy Penny stocks generally trade for $5 per share, which makes them some of the most appealing for new or novice traders. The ability to purchase hundreds, thousands, or even millions of shares for a couple of hundred dollars gives way to scoring big when stocks ex...

If you’re looking for the best penny stocks to buy, you likely understand the disconnect between broader trends and cheap stocks. Since penny stocks move independently, most of the time, you’re sure to find at least a few companies to follow. Today this became more evi...

Summary Two new Breakout Stocks for Week 40 with better than 10% short-term upside potential and one Dow 30 pick. Average cumulative returns now up to +105.6% YTD. This week 2 picks beat 10% in less than a week with FUSN +12.2%, LRMR at +12.95% and VYGR +9.2% peak gains continuing...

Six presentations and posters between OTS and ESGCT meetings will highlight Wave’s oligonucleotide chemistry advancements as well as RNA editing and RNAi capabilities First presentation in a scientific congress of preclinical data supporting WVE-006 as a potential best-in...

WVE-006 is the most advanced candidate for AATD designed to restore functional wild-type AAT protein and reduce Z-AAT protein aggregation with potential for disease modification in both lung and liver phenotypes IND-enabling activities for WVE-006 are underway and Wave expects t...

CAMBRIDGE, Mass., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Exe...

Summary Two new Breakout Stocks for Week 39 with better than 10% short-term upside potential and a Dow 30 Pick. Average cumulative returns now down to +108.7% YTD. This week no picks beat 10% gains in less than a week with SLCR peak at +7.1% and continuing the highest negative Mom...